Page last updated: 2024-08-23

ilepcimide and Allergic Encephalomyelitis

ilepcimide has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, J; Huang, J; Liu, X; Liu, Z; Lu, S; Lu, W; Tang, L; Wang, W; Xu, Z	1

Other Studies

1 other study(ies) available for ilepcimide and Allergic Encephalomyelitis

Article	Year
Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress. Toxicology and applied pharmacology, 2023, 01-01, Volume: 458 Topics: Animals; CD8-Positive T-Lymphocytes; Dihydroorotate Dehydrogenase; Disease Models, Animal; Drug Repositioning; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Multiple Sclerosis; Oxidative Stress	2023

Article

Year

Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress.

Toxicology and applied pharmacology, 2023, 01-01, Volume: 458

Topics: Animals; CD8-Positive T-Lymphocytes; Dihydroorotate Dehydrogenase; Disease Models, Animal; Drug Repositioning; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Multiple Sclerosis; Oxidative Stress

2023